Related Experiment Video
Updated: May 7, 2026
07:09
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Summary
Fibrinolytic activity in colonic blood showed no differences between inflammatory bowel disease and other colonic conditions. Low peripheral fibrinolytic activity was linked to postoperative blood clots.
Area of Science:
- Gastroenterology
- Hematology
- Surgical Oncology
Background:
- Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's colitis, involves significant gastrointestinal inflammation.
- Colonic conditions such as carcinoma and diverticulosis present distinct challenges in surgical management.
- Understanding the hemostatic and fibrinolytic profiles in these conditions is crucial for managing surgical risks.
Purpose of the Study:
- To investigate and compare the fibrinolytic activity in colic venous and arterial blood.
- To determine if fibrinolytic activity differs between patients with IBD and those with colonic carcinoma or diverticulosis.
- To correlate fibrinolytic activity with clinical complications like bleeding or thrombosis.
Main Methods:
- Laparotomy was performed on patients with ulcerative colitis or Crohn's colitis (n=18) and colonic carcinoma or diverticulosis (n=17).
- Fibrinolytic activity was assessed using the dilute blood clot lysis time technique in both colic venous and arterial blood samples.
- Peripheral venous fibrinolytic activity was also evaluated and compared with clinical outcomes.
Main Results:
- No significant difference in fibrinolytic activity was observed in colic venous blood between the IBD group and the colonic carcinoma/diverticulosis group.
- A notable association was found between low peripheral venous fibrinolytic activity and the incidence of postoperative thrombo-embolic complications.
- Fibrinolytic activity in colic arterial blood was not explicitly detailed in its comparative findings.
Conclusions:
- Fibrinolytic activity within the colon does not appear to be a distinguishing factor between IBD and other common colonic pathologies.
- Peripheral venous fibrinolytic activity is a potential predictive marker for postoperative thrombo-embolic events in patients undergoing colonic surgery.
- Further research may elucidate the role of localized vs. systemic fibrinolysis in colonic disease management.
Related Concept Videos
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...